Advanced Spatial Biology and Biomarker Services
Comprehensive data-driven solutions for deeper clinical insights
Precision Solutions for Your Unique Endpoints
Flagship Biosciences offers a broad range of CAP-accredited, CLIA-certified histology, molecular, flow cytometry, and cytogenetic services to meet the unique needs of your clinical development. We provide end-to-end support from pre-IND to commercialization by leveraging our proprietary technologies to maximize every sample in your trial.
IHC Assays, IF Assays, & ISH Assays
Gain new insights via spatial analysis of cell populations and biomarker expression patterns.
Multiplex Assays
Analyze multiple biomarkers simultaneously for contextual insights using custom or off-the-shelf panels.
Spatial Multiplex Services
Spatial genomics and transcriptomics using highly multiplexed profiling techniques
Molecular Solutions
Whole exome sequencing, RNA sequencing, and proprietary NGS panels
Flow Cytometry & Cytogenetics
Take tissue characterization farther with biomarker and genetic analysis of individual cell populations.
Immunoassays
Detect and quantify your biomarkers with high specificity.
Bioinformatics Solutions
Tailored pipelines for sequencing and biomarker analysis
Biomarker Discovery and Development
Advanced spatial biomarker solutions: IHC/IF/ISH assays, multiplex assays, immunoassays, anatomical pathology, flow cytometry, and cytogenetics
Integrated Biorepository
Sample management including custom collection kits and GLP-compliant, ISBER-compliant storage facilities
Data Analysis and Reporting
Standard data reporting or customized data “deep dives”
Consultation with Scientific Experts
Guidance in pathology, biology, image analysis, data science, and artificial intelligence
Regulatory Strategy and Support
Strategic regulatory consulting and integrated regulatory submissions support
| Pre-IND | Phase I | Phase II | Phase III |
Phase IV /Commercialization |
||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
||||
|
Biomarker Discovery and Development |
|
|||||||
|
|
|
|
|
|
||||
|
Genomics Application |
||||||||
|
|
|
|
|
|
||||
|
|
|
|
|
spatialplex |
Spatial Multiplex Services |
|||
|
|
|
|
|
|
||||
|
|
|
|
|
|
||||
|
Pre-Clinical /Pre-IND |
Phase I | Phase II | Phase III |
Phase IV /Commercialization |
||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
||||
|
Biomarker Discovery and Development |
|
|||||||
|
|
|
|
|
|
||||
|
Genomics Application |
||||||||
|
|
|
|
|
|
||||
|
|
|
|
|
spatialplex |
Spatial Multiplex Services |
|||
|
|
|
|
|
|
||||
|
|
|
|
|
|
||||
READY TO TAKE THE NEXT STEP?
Our Services
Pharma
Cell-based image analysis, assays, and partnership to advance clinical trials and regulatory acceptance.
Clinical Diagnostics
Dependable clinical diagnostic testing to connect patients to individualized, immuno-oncology therapies.
